TGA warning for top drug class
The TGA has followed in the footsteps of its overseas counterparts and added intestinal obstruction, including ileus, as a potential adverse effect to the Product Information (PI) of all GLP-1 receptor agonists (RAs) available in Australia.
To see the whole article please log in.